Recovery Therapy Trial

Schizophrenia Clinical Trial

Official title:

Applicability of CBT to Unselected Mental Health Service Clients With Psychotic Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00239122
• Other study ID #: E00013
• Status: Completed
• Phase: N/A
• First received: October 12, 2005
• Last updated: October 12, 2005
• Start date: June 2000
• Est. completion date: February 2004

Study information

• Verified date: October 2005
• Source: Melbourne Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: Australia: National Health and Medical Research Council
• Study type: Interventional

Clinical Trial Summary

This project will systematically apply a specialist version of Cognitive Behaviour Therapy (CBT), known as Recovery Therapy, to a random sample of patients with psychotic disorders. Previously, the therapy has been developed and efficacy established, but the extent of applicability to (unselected) mental health service patients is unknown. The main aim is to establish the extent to which this therapy is acceptable and effective for mental health service clients. A secondary aim is to develop guidelines for the conduct of such therapy in public mental health settings.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 94
• Est. completion date: February 2004
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years to 65 Years

Eligibility

Inclusion Criteria:

• acceptance by the participating Community Mental Health Services for case management

• a preliminary DSM-IV diagnosis of schizophrenia, schizoaffective disorder, mood disorder with psychotic features, or delusional disorder

• a recovery "need" in one of the areas addressed by the therapy

Exclusion Criteria:

• a preliminary DSM-IV diagnosis of brief psychotic disorder, drug-induced psychosis, mood disorder without hallucinations or delusions, or any other disorder (eg. personality disorder, PTSD) even where psychotic features are/have been present

• non-English speaking

• comorbid intellectual disability

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Disease
• Mental Disorders
• Mood Disorders
• Psychotic Disorders
• Schizophrenia

Intervention

Behavioral:
• Recovery Therapy (Cognitive Behaviour Therapy for psychosis)

Locations

Country	Name	City	State
Australia	Whittlesea Community Mental Health Service	Epping	Victoria
Australia	Darebin Community Mental Health Service	Preston	Victoria

Sponsors (2)

Lead Sponsor	Collaborator
Melbourne Health	William Buckland Foundation

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To determine the applicability of cognitive behaviour therapy for psychosis in the "real world" setting of ordinary mental health services
Secondary	To establish rates of uptake of Recovery Therapy amongst clients at a community mental health service
Secondary	To establish effectiveness of therapy in clients who received a defined length of therapeutic contact (12-24 sessions)
Secondary	To identify factors predicting uptake and effectiveness